M
$ Value
—
Shares
1,667
Price
—
Filed
Sep 9
Insider
Name
Schoenberg Mark
Title
Chief Medical Officer
CIK
0001763581
Roles
Officer
Transaction Details
Transaction Date
2025-09-07
Code
M
Table
Non-Derivative
Ownership
Direct
Equity Swap
No
Shares After
149,896
Footnotes
Each restricted stock unit ("RSU") represents a contingent right to receive one ordinary share of the Issuer. | Represents shares sold to satisfy withholding tax obligations upon the settlement of restricted stock units. | The reporting person was granted RSUs on September 7, 2023 representing 5,000 ordinary shares. The RSUs will vest in three equal annual installments from September 7, 2024.
Filing Info
Schoenberg Mark's History
| Date | Ticker | Type | Value |
|---|---|---|---|
| 2026-02-03 | URGN | ▼ | $36K |
| 2026-02-03 | URGN | ▼ | $36K |
| 2026-02-03 | URGN | ▼ | $73K |
| 2026-01-31 | URGN | M | — |
| 2026-01-31 | URGN | M | — |
| 2026-01-31 | URGN | M | — |
| 2026-01-31 | URGN | M | $0 |
| 2026-01-31 | URGN | M | $0 |
| 2026-01-31 | URGN | M | $0 |
| 2026-01-31 | URGN | A | $0 |
Other Insiders at URGN (90d)
| Insider | Bought | Sold | Last |
|---|---|---|---|
| Robinson James A. Jr. | — | — | 2025-02-26 |
|
Degnan Chris
Chief Financial Officer
|
— | — | 2026-01-31 |
|
Schoenberg Mark
Chief Medical Officer
|
— | $145K | 2026-02-03 |
|
Barrett Elizabeth A.
Chief Executive Officer
|
— | — | 2026-01-31 |
|
Smith Jason Drew
General Counsel
|
— | $147K | 2026-02-03 |